We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.68%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$2.54B
(+14%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$798M |
| 2 |
ExxonMobil
XOM
|
+$189M |
| 3 |
Cognizant
CTSH
|
+$86.4M |
| 4 |
Merck
MRK
|
+$80.6M |
| 5 |
Integra LifeSciences
IART
|
+$47.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$57.5M |
| 2 |
PepsiCo
PEP
|
+$55.1M |
| 3 |
Dollar General
DG
|
+$49.7M |
| 4 |
WOOF
VCA Inc.
WOOF
|
+$48.1M |
| 5 |
Simon Property Group
SPG
|
+$45.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.52% |
| 2 | Technology | 14.11% |
| 3 | Financials | 12.07% |
| 4 | Industrials | 10.58% |
| 5 | Consumer Discretionary | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACOR
651
DELISTED
Acorda Therapeutics
ACOR
| $1.29M | 0.01% |
513
+2
| +0.4% | +$5.76K |
|
652
United Rentals
URI
$71.1B
| $1.29M | 0.01% |
10,334
+9,706
| +1,546% | +$1.18M |
|
653
Stryker
SYK
$127B
| $1.27M | 0.01% |
9,656
+1,824
| +23% | +$230K |
|
654
Chemours
CC
$2.59B
| $1.27M | 0.01% |
33,016
+8,278
| +33% | +$249K |
|
655
Tetra Tech
TTEK
$8.23B
| $1.27M | 0.01% |
155,495
+415
| +0.3% | +$3.44K |
|
656
State Street SPDR S&P Dividend ETF
SDY
$21.9B
| $1.26M | 0.01% |
14,359
-23
| -0.2% | -$2.01K |
|
657
Saic
SAIC
$5.03B
| $1.25M | 0.01% |
16,782
| – | – |
|
658
Park Hotels & Resorts
PK
$2.97B
| $1.23M | 0.01% |
+47,967
| New | +$1.27M |
|
659
Arthur J. Gallagher & Co
AJG
$63.7B
| $1.21M | 0.01% |
21,382
+12,314
| +136% | +$679K |
|
660
Essent Group
ESNT
$6.06B
| $1.21M | 0.01% |
33,420
| – | – |
|
|
NSH
661
DELISTED
NuStar GP Holdings LLC
NSH
| $1.19M | 0.01% |
42,643
-1,000
| -2% | -$29.5K |
|
|
TCP
662
DELISTED
TC Pipelines LP
TCP
| $1.17M | 0.01% |
19,580
| – | – |
|
663
Equity Lifestyle Properties
ELS
$12.8B
| $1.17M | 0.01% |
30,280
| – | – |
|
664
CoreCivic
CXW
$3.1B
| $1.17M | 0.01% |
37,136
+36,688
| +8,189% | +$1.12M |
|
665
Hubbell
HUBB
$25.7B
| $1.15M | 0.01% |
9,622
+968
| +11% | +$116K |
|
666
Minerals Technologies
MTX
$2.31B
| $1.14M | 0.01% |
14,856
+36
| +0.2% | +$2.79K |
|
667
Dover
DOV
$27.2B
| $1.14M | 0.01% |
17,516
+398
| +2% | +$25.4K |
|
668
Aecom
ACM
$9.07B
| $1.13M | 0.01% |
31,865
+3,570
| +13% | +$131K |
|
|
PSXP
669
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $1.13M | 0.01% |
22,080
+5,400
| +32% | +$288K |
|
670
State Street Industrial Select Sector SPDR ETF
XLI
$33.9B
| $1.13M | 0.01% |
17,357
+270
| +2% | +$17.4K |
|
671
L3Harris
LHX
$55.9B
| $1.12M | 0.01% |
10,108
-776
| -7% | -$83K |
|
672
Belden
BDC
$4B
| $1.12M | 0.01% |
16,177
-218
| -1% | -$16K |
|
673
Unilever
UL
$131B
| $1.09M | 0.01% |
19,750
+1,584
| +9% | +$80.1K |
|
|
SVC
674
Service Properties Trust
SVC
$1.1B
| $1.09M | 0.01% |
6,923
-3
| -0% | -$470 |
|
|
FISV
675
Fiserv Inc
FISV
$27.2B
| $1.06M | 0.01% |
18,484
-1,106
| -6% | -$62.1K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2017 Portfolio in Review
As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.
- Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
- Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
- Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
- Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
- Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
- Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
- Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.
Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.